MENLO PARK, Calif., June 30, 2023 /PRNewswire/ -- Gamma Biosciences, a life sciences platform created by global investment firm KKR to address the advanced therapy bioprocessing market, today announced that its operating company, Univercells Technologies ("UT"), a leading provider of novel biomanufacturing technologies for flexible and scalable advanced therapies and vaccine production, has been acquired by Donaldson Company, Inc. (NYSE: DCI).
Read more at prnewswire.comhello world
Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.
